C-reactive protein in young individuals: Problems and implications for Asian Indians

Nutrition

Volumn 20, Issue 5, 2004, Pages 478-481

  Misra, Anoop ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Asian Indians; C reactive protein; Children; Coronary heart disease; Diabetes; Obesity

Indexed keywords

C REACTIVE PROTEIN;

ANALYTICAL PARAMETERS; ANTHROPOMETRY; ASIAN; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; ETHNOLOGY; GROUPS BY AGE; HUMAN; INDIAN; INFLAMMATION; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; REVIEW; RISK FACTOR;

EID: 16544365356     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2004.01.019     Document Type: Article

References (47)

1. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. Comparison of C- reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 347:2002;1557.
2. Danesh J., Whincup P., Walker M., et al. Low grade inflammation and coronary heart disease Prospective study and updated meta-analyses. BMJ. 321:2000;199.
3. Chambers J.C., Eda S., Bassett P., et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation. 104:2001;145.
4. Tamakoshi K., Yatsuya H., Kondo T., et al. The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obes Relat Metab Disord. 27:2003;443.
5. Ford E.S. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count Findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis. 168:2003;351.
6. Festa A., D'Agostino R. Jr, Howard G., Mykkanen L., Tracy R.P., Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome The Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 102:2000;42.
7. Frohlich M., Imhof A., Berg G., et al. Association between C-reactive protein and features of the metabolic syndrome A population-based study. Diabetes Care. 23:2000;1835.
8. Ford E.S., Giles W.H. Serum C-reactive protein and self-reported stroke Findings from the Third National Health and Nutrition Examination Survey. Arterioscler Thromb Vasc Biol. 20:2000;1052.
9. Cao JJ, Thach C, Manolio TA, et al. C-reactive protein, carotid intima-media thickness and incidence of ischemic stroke in the elderly. The Cardiovascular Health Study. Circulation 2003
10. Brevetti G., Piscione F., Silvestro A., et al. Increased inflammatory status and higher prevalence of three-vessel coronary artery disease in patients with concomitant coronary and peripheral atherosclerosis. Thromb Haemost. 89:2003;1058.
11. Freeman D.J., Norrie J., Caslake M.J., et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes. 51:2002;1596.
12. Han T.S., Sattar N., Williams K., Gonzalez-Villalpando C., Lean M.E., Haffner S.M. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care. 25:2002;2016.
13. de Ferranti S., Rifai N. C-reactive protein and cardiovascular disease A review of risk prediction and interventions. Clin Chim Acta. 317:2002;1.
14. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease Application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 107:2003;499.
15. Yeh E.T., Willerson J.T. Coming of age of C-reactive protein Using inflammation markers in cardiology. Circulation. 107:2003;370.
16. Pepys M.B., Hirschfield G.M. C-reactive protein A critical update. J Clin Invest. 111:2003;1805.
17. Torzewski M., Rist C., Mortensen R.F., et al. C-reactive protein in the arterial intima Role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol. 20:2000;2094.
18. Zwaka T.P., Hombach V., Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages Implications for atherosclerosis. Circulation. 103:2001;1194.
19. Pepys M.B., Rowe I.F., Baltz M.L. C-reactive protein Binding to lipids and lipoproteins. Int Rev Exp Pathol. 27:1985;83.
20. Bhakdi S., Torzewski M., Klouche M., Hemmes M. Complement and atherogenesis Binding of CRP to degraded, nonoxidized LDL enhances complement activation. Arterioscler Thromb Vasc Biol. 19:1999;2348.
21. Cermak J., Key N.S., Bach R.R., Balla J., Jacob H.S., Vercellotti G.M. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood. 82:1993;513.
22. Yusuf S., Reddy S., Ounpuu S., Anand S. Global burden of cardiovascular diseases Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation. 104:2001;2855.
23. Reddy K.S., Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 97:1998;596.
24. Misra A., Pandey R.M., Devi J.R., Sharma R., Vikram N.K., Khanna N. High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Int J Obes Relat Metab Disord. 25:2001;1722.
25. Misra A, Vikram NK. Insulin resistance syndrome (metabolic syndrome) and Asian Indians. Curr Sci 2002;83:1483. Available at: http://tejas.serc.iisc. ernet.in/∼currsci
26. Misra A. Insulin resistance syndrome Current perspective and its relevance in Indians. Indian Heart J. 50:1998;385.
27. Forouhi N.G., Sattar N., McKeigue P.M. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord. 25:2001;1327.
28. Cook D.G., Mendall M.A., Whincup P.H., et al. C-reactive protein concentration in children Relationship to adiposity and other cardiovascular risk factors. Atherosclerosis. 149:2000;139.
29. Sethi A., Misra A., Pandey R.M., et al. Soluble inter-cellular adhesion molecule-1 in urban Asian North Indians Relationships with anthropometric and metabolic covariates. Dis Markers. 18:2002;111.
30. Vikram N.K., Misra A., Dwivedi M., et al. Correlations of C-reactive protein levels with anthropometric profile, percentage of body fat and lipids in healthy adolescents and young adults in urban North India. Atherosclerosis. 168:2003;305.
31. Singh V., Trikha B., Nain C.K., Singh K., Vaiphei K. Epidemiology of Helicobacter pylori and peptic ulcer in India. J Gastroenterol Hepatol. 17:2002;659.
32. Hutchinson W.L., Koenig W., Frohlich M., Sund M., Lowe G.D., Pepys M.B. Immunoradiometric assay of circulating C-reactive protein Age-related values in the adult general population. Clin Chem. 46:2000;934.
33. Brull DJ, Serrano N, Zito F, et al. Human CRP gene polymorphism influences CRP levels: Implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 2003;23:2063
34. Misra A. Risk factors for atherosclerosis in young individuals. J Cardiovasc Risk. 7:2000;215.
35. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., Harris T.B. Low-grade systemic inflammation in overweight children. Pediatrics. 107:2001;E13.
36. Ford E.S., Galuska D.A., Gillespie C., Will J.C., Giles W.H., Dietz W.H. C- reactive protein and body mass index in children Findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Pediatr. 138:2001;486.
37. Shea S., Aymong E., Zybert P., et al. Obesity, fasting plasma insulin, and C-reactive protein levels in healthy children. Obes Res. 11:2003;95.
38. Wu D.M., Chu N.F., Shen M.H., Chang J.B. Plasma C-reactive protein levels and their relationship to anthropometric and lipid characteristics among children. J Clin Epidemiol. 56:2003;94.
39. Barbeau P., Litaker M.S., Woods K.F., et al. Hemostatic and inflammatory markers in obese youths Effects of exercise and adiposity. J Pediatr. 141:2002;415.
40. Ford E.S. C-reactive protein concentration and cardiovascular disease risk factors in children Findings from the National Health and Nutrition Examination Survey 1999-2000. Circulation. 108:2003;1053.
41. Jarvisalo M.J., Harmoinen A., Hakanen M., et al. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol. 22:2002;1323.
42. Ford E.S. Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiology. 13:2002;561.
43. Isasi C.R., Deckelbaum R.J., Tracy R.P., Starc T.J., Berglund L., Shea S. Physical fitness and C-reactive protein level in children and young adults The Columbia University BioMarkers Study. Pediatrics. 111:2003;332.
44. Ferguson M.A., Gutin B., Owens S., Barbeau P., Tracy R.P., Litaker M. Effects of physical training and its cessation on the hemostatic system of obese children. Am J Clin Nutr. 69:1999;1130.
45. Isasi C.R., Starc T.J., Tracy R.P., Deckelbaum R., Berglund L., Shea S. Inverse association of physical fitness with plasma fibrinogen level in children The Columbia University BioMarkers Study. Am J Epidemiol. 152:2000;212.
46. Invitti C., Guzzaloni G., Gilardini L., Morabito F., Viberti G. Prevalence and concomitants of glucose intolerance in European obese children and adolescents. Diabetes Care. 26:2003;118.
47. Hiura M., Kikuchi T., Nagasaki K., Uchiyama M. Elevation of serum C-reactive protein levels is associated with obesity in boys. Hypertens Res. 26:2003;541.